Search research articles
Contact Us
Filters
Showing results (141-150 of 659) with videos related to
Page
of 66
Sort By:
Pharmacogenomics
|
June 9, 2012
Institutional profile: The Carney Centre for Pharmacogenomics: a New Zealand focus for personalized medicine research
Martin A Kennedy, Peter R Joyce, Evan J Begg
Journal of Psychiatric Research
|
January 1, 1986
Physostigmine reduces the plasma cortisol response to methylphenidate in normal subjects
P R Joyce, R A Donald, M G Nicholls
CJEM
|
September 5, 2024
Updated guidelines for SSTIs: sensible recommendations for greater consistency
Martin Than, Laura R Joyce, Sarah C L Metcalf
Journal of Psychopharmacology (Oxford, England)
|
April 12, 2003
The prolactin response to fenfluramine in depression: effects of melancholia and baseline cortisol
Roger T Mulder, Richard J Porter, Peter R Joyce
Psychopharmacology
|
November 20, 2002
Baseline prolactin and L-tryptophan availability predict response to antidepressant treatment in major depression
Richard J Porter, Roger T Mulder, Peter R Joyce
Journal of Affective Disorders
|
March 1, 1985
A relationship between prolactin levels and dexamethasone suppression test results in major depressive disorder
P R Joyce, R A Donald, J H Livesey
Public Health
|
April 29, 2000
Which is the best deprivation predictor of foetal and infant mortality rates?
R Joyce, R Webb, J L Peacock, et al.
The American Journal of Psychiatry
|
February 1, 1994
Temperament and hypercortisolemia in depression
P R Joyce, R T Mulder, C R Cloninger
American Journal of Perinatology
|
January 1, 1992
Pregnancy in renal transplant recipients: case report
T W Robinson, S A Wilkerson, M R Joyce
Journal of Affective Disorders
|
January 1, 1987
Individual differences in plasma cortisol changes during mania and depression
P R Joyce, R A Donald, P A Elder
Page
of 66
Search research articles
Search
Showing results (141-150 of 659) with videos related to
Sort By:
Page
of 66
Pharmacogenomics
|
June 9, 2012
Institutional profile: The Carney Centre for Pharmacogenomics: a New Zealand focus for personalized medicine research
Martin A Kennedy, Peter R Joyce, Evan J Begg
Journal of Psychiatric Research
|
January 1, 1986
Physostigmine reduces the plasma cortisol response to methylphenidate in normal subjects
P R Joyce, R A Donald, M G Nicholls
CJEM
|
September 5, 2024
Updated guidelines for SSTIs: sensible recommendations for greater consistency
Martin Than, Laura R Joyce, Sarah C L Metcalf
Journal of Psychopharmacology (Oxford, England)
|
April 12, 2003
The prolactin response to fenfluramine in depression: effects of melancholia and baseline cortisol
Roger T Mulder, Richard J Porter, Peter R Joyce
Psychopharmacology
|
November 20, 2002
Baseline prolactin and L-tryptophan availability predict response to antidepressant treatment in major depression
Richard J Porter, Roger T Mulder, Peter R Joyce
Journal of Affective Disorders
|
March 1, 1985
A relationship between prolactin levels and dexamethasone suppression test results in major depressive disorder
P R Joyce, R A Donald, J H Livesey
Public Health
|
April 29, 2000
Which is the best deprivation predictor of foetal and infant mortality rates?
R Joyce, R Webb, J L Peacock, et al.
The American Journal of Psychiatry
|
February 1, 1994
Temperament and hypercortisolemia in depression
P R Joyce, R T Mulder, C R Cloninger
American Journal of Perinatology
|
January 1, 1992
Pregnancy in renal transplant recipients: case report
T W Robinson, S A Wilkerson, M R Joyce
Journal of Affective Disorders
|
January 1, 1987
Individual differences in plasma cortisol changes during mania and depression
P R Joyce, R A Donald, P A Elder
Page
of 66